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ABSTRACT
Current literature describes several methods for
the design of efficient siRNAs with 19 perfectly
matched base pairs and 2nt overhangs. Using four
independent databases totaling 3336 experimentally
verified siRNAs, we compared how well several of
these methods predict siRNA cleavage efficiency.
According to receiver operating characteristics
(ROC) and correlation analyses, the best programs
were BioPredsi, ThermoComposition and DSIR.W e
also studied individual parameters that significantly
and consistently correlated with siRNA efficacy
in different databases. As a result of this work we
developed a new method which utilizes linear
regression fitting with local duplex stability, nucleo-
tide position-dependent preferences and total G/C
content of siRNA duplexes as input parameters. The
new method’s discrimination ability of efficient and
inefficient siRNAsis comparablewith thatofthebest
methods identified, but its parameters are more
obviously related tothe mechanisms of siRNA action
in comparison with BioPredsi. This permits insight to
the underlying physical features and relative impor-
tance of the parameters. The new method of
predicting siRNA efficiency is faster than that
of ThermoComposition because it does not employ
time-consuming RNA secondary structure calcula-
tions and has much less parameters than DSIR.I ti s
available as a web tool called ‘siRNA scales’.
INTRODUCTION
This work addresses chemically synthesized siRNAs.
After introduction of siRNAs into cells in the form of
synthetic oligonucleotide duplexes, there is speciﬁc
cleavage and subsequent degradation of target mRNAs,
but the mRNA cleavage eﬃcacy varies. Predicting the
cleavage eﬃcacy of siRNAs is an important task, the
success of which inﬂuences the prospects of using this
comparatively new method for genetic studies. The ﬁrst
attempt to compare siRNA eﬃcacy predictors was
done in 2004 by Sætrom (1). The eﬃcacy of siRNAs is
now predicted using several approaches and webtools
developed in the last two years following analyses of
experimental data. There is no clear indication yet as to
which approach or web tool is optimal (2–22) and what
siRNA features are crucial for the optimal prediction
(23,24).
All parameters (See Appendix note 1) in the
methods currently in use are either related (group 1), or
unrelated (group 2), to the stability of the siRNA duplex
termini. Group 1 includes the duplex termini stability (as
calculated by G0
37), or the presence or absence of a
speciﬁc nucleotide at a certain duplex terminal position.
Group 2 includes, for example, the percentage of a
particular nucleotide in the sense or antisense strand of
siRNA, the presence or absence of a speciﬁc nucleotide at
a certain internal position, the stability of secondary
structures of target mRNA or the stability of the siRNA
antisense strand.
The rules for group 1 relate to siRNA strand entry
into the RNA-induced silencing complex (RISC);
entry of the siRNA antisense strand is critical for
mRNA cleavage. The siRNA duplex strand with the
least stable 50 end enters RISC faster than the other
strand (2,4). Accordingly, the 50 end of the strand
that is antisense to the target, has to be AU-rich and
its 30 end GC-rich. This is more formally captured by the
50 terminal free energy (G0
37) of the antisense strand and
the diﬀerence in 50 terminal free energy (G0
37) of the
sense and antisense strand.
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meters and lengths of terminal sequences ranging from
1 to 7nt (2,4–7), there is no uniformity in the current rules
for group 1. Also there is no general agreement about
the best way to calculate and apply the parameters for
group 2. Consequently, the currently developed webtools
for eﬃcient siRNA design frequently employ variable,
user adjustable settings for specifying parameters and
selection rules in their algorithms. To make users better
equipped to choose the best design algorithm and
parameter settings, we compared several existing
approaches on the several thousand experimental data
points recently generated (2,4,8,25). Furthermore, we used
the largest of these datasets to develop a new method with
optimal group 1 and group 2 parameters.
RESULTS
We collected siRNA experimental databases using pre-
viously described siRNA silencing experiments performed
at Isis Pharmaceuticals (25), Amgen (4), Dharmacon (2),
Sloan Kettering Cancer Center (9) and Novartis (8). The
data produced by Amgen and Dharmacon were pooled
together in one database for the present work. All
databases are presented in Table 1 and are available
for downloading from http://gesteland.genetics.utah.edu/
members/olgaM/siRNA_database_September_2006.xls
Comparison and performanceevaluation of published siRNA
design algorithms
Our ﬁrst goal was to compare the siRNA design
approaches described in published literature. Two criteria
were used for choosing approaches for the comparison
study. The approach had to be either easily reproduced by
us or its authors had to be willing to cooperate by
calculating predicted siRNA eﬃcacy values for the four
experimental databases compiled for this study (Table 1).
The approaches used in this work are named according to
the ﬁrst and last authors of the relevant publications
(Figure 1).
We compared the approaches by using receiver
operating characteristics (ROC) and correlation
analyses (Figure 1). An ROC curve describes the relation-
ship between speciﬁcity and the sensitivity of an approach
(see Methods section). The area under the ROC curve
captures the approach’s overall performance such that an
area of 1 indicates a perfect classiﬁcation, and an area of
0.5 indicates a random classiﬁcation. We also performed
correlation analysis between experimentally determined
and predicted siRNA eﬃcacy (Figure 1). For correlation
and ROC analyses, the levels of mRNA or proteins
remaining in cells after siRNA treatments were expressed
as percentages of the control levels. For ROC analysis,
siRNAs that yielded at least 70% target gene knockdown
were considered to be eﬃcient; other siRNAs were
considered ineﬃcient.
All analyzed approaches can, to some degree, discrimi-
nate between eﬃcient and ineﬃcient siRNAs. The
correlation coeﬃcients are signiﬁcant and the areas
under the ROC curves are higher than 0.5 for all
approaches and for all databases. All ROC values
obtained with all the approaches are signiﬁcant for
the three largest databases (Amgen/Dharmacon, Sloan-
Kettering, Novartis). BioPredsi by Huesken-Hall (8),
ThermoComposition by Shabalina-Ogurtsov (10) and
DSIR by Vert-Vandenbrouck (11) have better perfor-
mance than the others. These three approaches have the
highest absolute correlation coeﬃcient values and
the largest areas under their ROC curves on all datasets
(Figure 1). Furthermore, whereas the performance of the
other approaches varies on the diﬀerent datasets,
BioPredsi, ThermoComposition and DSIR have statisti-
cally similar performance on all datasets (performance
measured in terms of ROC-area and sensitivity at
highly speciﬁc algorithm thresholds; see Supplementary
Tables 6–10 online).
The neural network BioPredsi approach by
Huesken-Hall was trained using siRNAs in which the
antisense strands (21-mers) were completely complemen-
tary to mRNA. In the databases from Isis, Amgen/
Dharmacon and SloanKettering, mainly 19 mRNA
nucleotides were targeted. Only a small subset of the
data (223 data points) was represented by siRNAs in
which dTdT overhangs in the siRNA antisense strands
were complementary to ‘AA’ dinucleotides in mRNAs.
For fairly evaluating the performance of the BioPredsi
algorithm, we chose this subset of data and calculated the
areas under the ROC curves and correlation coeﬃcients
for the predicted and experimentally obtained data. For
this subset, the BioPredsi algorithm shows a better
correlation coeﬃcient, but the area under the ROC
curve did not improve (Figure 1).
We used two versions of the ThermoComposition
algorithm in this work. One version was trained on a
heterogeneous set of 653 siRNAs to classify 19-mers (10).
The other version was trained on the Novartis database to
classify 21-mers. Both versions used correlation and
Student’s t-test analyses to determine position-dependent
nucleotide preferences and avoidances, and used linear
regression to combine these into siRNA eﬃcacy predic-
tors. As we used the Novartis database to train the
21-mer version, the reported prediction results on
this dataset are from a standard non-overlapping cross-
validation experiment. Both the 19-mer and 21-mer
Table 1. Summary of features of experimental databases
Base Database
name
Concentration
of siRNAs
(nM)
Success
rate in
database
(eﬃcient
siRNAs
versus total
amount)
Total
Number
of siRNAs
tested
(n)
1 Isis Pharmaceuticals 100 9 67
2 Amgen/Dharmacon 100 56 238
3 Sloan Kettering 100 30 601
4 Novartis 50 50 2430
For success rate calculations, siRNAs that yielded at least 70% target
gene silencing, were considered to be eﬃcient. Other siRNAs were
considered to be ‘ineﬃcient’.
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shabalin/siRNA/ThermoComposition
It was shown that the performance of approaches based
on both thermodynamic and composition features is
almost identical for neural networks and linear regression
(10). Our next goals were (1) to analyze parameters used
in the described approaches and (2) to create a regression
method based on the best parameters.
Parameter selection
Using correlation analyses, we studied the inﬂuence
of such parameters as siRNA local duplex
stability (measured as G0
37 for two neighboring
nucleotides), nucleotide position preferences and total
G/C content on siRNA eﬃcacy in the four experimental
databases.
Duplex stability profile. We analyzed the correlation
between observed siRNA eﬃcacy and thermodynamic
stability (G0
37) calculated for every two base pairs along
the duplex siRNA antisense strand. Thermodynamic
parameters for the calculations were published earlier
(26). Only correlation coeﬃcients that are signiﬁcant
(P50.05) at least in two databases, are shown (Figure
2). Relationships between siRNA eﬃcacy and G0
37 are
strongest and most consistent for the ﬁrst and last two
base pairs. The second and third two base pairs
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Figure 1. A comparison of siRNA eﬃcacy predictors on four experimental databases (9 published approaches). The list of analyzed approaches
included: ‘8 criteria algorithm’ by Reynolds–Khvorova (2), four rules algorithm by Ui Tei-Saigo (6) version 1, four rules scoring algorithm by Ui Tei-
Saigo version 2 modiﬁed by us (described in this study, see Appendix note 2), a decision tree based algorithm by Jagla–Rothman (9), genetic
programming algorithm Gpboost by Sætrom (3), 6 criteria algorithm by Amarzguioui-Prydz (5), algorithm created by Henschel-Habermann (12) used
by program DEQOR, BioPredsi algorithm by Huesken-Hall (8), ThermoComposition by Shabalina-Ogurtsov (10) and DSIR by Vert-Vandenbrouck
(11). The histogram was created on the basis of the analysis of four databases and one data subset using published and unpublished siRNA design
algorithms. For each database and each algorithm, the area under a corresponding ROC curve, as well as the correlation coeﬃcient between
experimental and theoretically predicted siRNA eﬃcacy, were calculated. The star indicates that the relevant databases were used for creating the
algorithm. So, the statistical characteristics (correlation coeﬃcient and area under ROC curve values) might be positively overestimated for these
cases. The right part of the histogram shows the areas under the ROC curves. The left part of the histogram shows correlation coeﬃcients between
experimentally obtained and predicted values of siRNA eﬃcacy. The signiﬁcance values for correlation and ROC analyses are reported in
‘Supplementary Table 1 online’. The columns with variable ﬁlling indicate diﬀerent databases.
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These observations provide evidence that the thermo-
dynamic stability in the ﬁrst two base pairs is a good
indicator of siRNA eﬃcacy and thermodynamic consid-
eration of four terminal nucleotides provides
poorer correlation with siRNA eﬃcacy (see Table 2).
Figure 2 also shows that some instability for two base
pairs at the 6th, 7th, 10th, 12th and 13th positions from
the 50 end of antisense strand might be related to siRNA
eﬃcacy.
Position-dependent consensus. To determine position-
dependent nucleotide preferences and avoidances, we
computed the correlation coeﬃcients between siRNA
eﬃcacy and the presence of A, G, C or U in the diﬀerent
positions in the antisense strand. Those coeﬃcients that
are signiﬁcant (P50.05) at least in two databases, are
shown in Figure 3. A positive correlation means that the
corresponding nucleotide is less frequently found in
eﬃcient siRNAs, while negative correlation means that
the corresponding nucleotide is more frequently found in
eﬃcient siRNAs. The strongest correlations with siRNA
eﬃcacy were found for U/A presence at the 50 end and for
G/C presence at the 30 end of the antisense strand.
The preferences and avoidance of other nucleotides at
diﬀerent positions of siRNA antisense strands which
are signiﬁcant (P50.05) for at least two databases, are
summarized in Table 3.
Total nucleotide content. We were unable to ﬁnd any
signiﬁcant correlation between siRNA eﬃcacy and total
nucleotide content of siRNA antisense strand (total A, G,
C and U), which are present in at least two experimental
datasets. So we focused our study on total GþC content.
It was shown before that GþC nucleotide content for
siRNA sequences is related to siRNA eﬃcacy (2). Here we
found a weight coeﬃcient (Supplementary Table 3 online)
for this parameter and used it in our new model. This
weight coeﬃcient is assigned for siRNA sequences
with GþC content being in the interval from 20 to
53%; for those that are outside the interval, a weight equal
to 0 is assigned.
Model selection
Inthisstudy,wechosetoworkwithlinearregressionrather
than with neural networks or other data mining techniques
that can pick up nonlinearity in relationships between
siRNA activity and a model’s parameters. It is likely that
linear relationships between model parameters and siRNA
eﬃcacy values are more common and consequently,
nonlinearity is rare (10). In addition, linear regression
models generate lists of relative weighting of the signiﬁcant
model parameters. So, for similar parameters such as
nucleotide identity at certain positions, their relative
importance for predicting siRNA eﬃcacy can be estab-
lished. This is much more diﬃcult to achieve using a neural
network approach (8), which does not reveal the relevant
importance of its input parameters. Linear regression
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Figure 2. Correlation between the siRNA eﬃcacy in cell and G0
37 values relevant to siRNA local duplex stability from position 1 to 18 in the
antisense strand. G0
37 values were calculated for each of two neighboring base pairs in siRNA duplexes starting from the 50 end of the antisense
strand. siRNA eﬃcacy values were measured as remaining levels of mRNA or normalized protein products levels. Only correlation coeﬃcients that
are signiﬁcant (P50.05) for at least in two databases, are shown.
Table 2. Evaluation of the relationships between siRNA eﬃcacy and theoretically calculated values
Base Database name G values of the 50 duplex
terminal base pairs
(50 antisense strand)
G values of the duplex
50 two base pairs (G 50 of
antisense strand minus
G of 50 of sense strand)
Output values
from model 1.
Two Four
1 Isis Pharmaceuticals  0.414 N.S.  0.450  0.475
2 Amgen/Dharmacon  0.355 N.S.  0.457  0.477
3 Sloan Kettering  0.370  0.344  0.477  0.487
4 Novartis  0.469  0.378  0.475  0.578
Correlation coeﬃcients calculated for G0
37 and G0
37 parameters as well as for model 1 output values. The signiﬁcance values for relevant
correlation coeﬃcients are shown in Supplementary Table 2 online.
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parameters; so for similar parameters such as nucleotide
identity atcertainpositions,theirrelative importance inthe
prediction of siRNA eﬃcacy can be established. This can
help in planning future experiments for ﬁnding functional
meaning of nucleotide preferences at certain positions. The
relative importance of speciﬁc nucleotides for siRNA
function is not easy to estimate using a neural network
approach.
A new methodfor siRNA design
Linear regression model with group 1 parameters. To
create a new method, we started to analyze group 1
parameters, which are related to the stability of siRNA
duplex termini. This stability is responsible for the rate of
entry of the duplex strands into RISC. Since we found
that G0
37 of the ﬁrst two base pairs in the antisense strand
correlates most strongly with siRNA eﬃcacy, we used this
parameter in our model. We also included G0
37 of the last
two base pairs in the antisense strand as it also showed
consistent and signiﬁcant correlation with siRNA eﬃcacy
(Figure 2).
The G0
37 values need to be adjusted for dangling end
eﬀects. The identity of the terminal 50 paired nucleotide of
siRNA duplexes and composition of 30 non-paired over-
hangs are related to these eﬀects. Including these factors
can improve the relationship of calculated terminal
siRNA duplex stability with siRNA eﬃcacy. Dangling
end parameters have been published for DNA and RNA
(27–30), but we are dealing with RNA sequences which
have DNA overhangs. Parameters for such hybrid DNA–
RNA sequences have not been published. Addition of
published DNA or RNA parameters did not improve our
model. Therefore, we made an attempt to add the identity
of nucleotides located at positions 1, 19, 20 and 21 in the
antisense strand into the linear regression model.
−0.4
−0.3
−0.2
−0.1
0
0.1
0.2
0.3
0.4
123456789 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9
C
o
r
r
e
l
a
t
i
o
n
 
c
o
e
f
f
i
c
i
e
n
t
−0.4
−0.3
−0.2
−0.1
0
0.1
0.2
0.3
0.4
C
o
r
r
e
l
a
t
i
o
n
 
c
o
e
f
f
i
c
i
e
n
t
−0.4
−0.3
−0.2
−0.1
0
0.1
0.2
0.3
0.4
C
o
r
r
e
l
a
t
i
o
n
 
c
o
e
f
f
i
c
i
e
n
t
−0.4
−0.3
−0.2
−0.1
0
0.1
0.2
0.3
0.4
C
o
r
r
e
l
a
t
i
o
n
 
c
o
e
f
f
i
c
i
e
n
t
Isis
Amgen/Dharmacon
Sloan Kettering"
Novartis
A
C
G
U
Nucleotide position 
123456789 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9
123456789 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9
123456789 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9
Figure 3. Correlation between the siRNA eﬃcacy in cell and nucleotide occurrence in the antisense strand of siRNA duplex. Nucleotide presence or
absence was registered for each position starting from the 50 end of the antisense strand. siRNA eﬃcacy values were measured as the remaining levels
of mRNA or normalized protein products levels. Only correlation coeﬃcients that are signiﬁcant (P50.05) at least in two databases, are shown.
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siRNA eﬃcacy value as the dependant variable and local
stability of siRNA duplex ends (G0
37), as well as
nucleotides located at positions 1, 19, 20, 21 in siRNA
duplex antisense strands, as independent variables. We
trained the model using the Novartis database and cross-
validated it using the remaining experimental databases.
The statistical values related to the model’s input
are shown in Supplementary Table 3 online. The
statistical values related to the model’s output are shown
in Figure 4. The correlation from the cross-validation
study demonstrates that the model output can predict
better siRNA eﬃcacy than G0
37 or G0
37 calculated for
two terminal nucleotide base pairs (Table 2).
Linear regression model with group 2 parameters. It is
known that local duplex stability values (G0
37) and
certain nucleotides at speciﬁc internal positions of siRNA
antisense strands can inﬂuence siRNA eﬃcacy. To more
accurately analyze these features and the GþC composi-
tion factor, a linear model with group 1 and 2 parameters
was created. The model integrated the parameters found
to be signiﬁcant for model 1 and the new group 2
parameters. These new parameters are described in the
‘Methods’ section. For the best correlation between
siRNA eﬃcacy and GþC content, an input weighting
value of 1 point was assigned for GC content in the
interval from 20 to 52% in 21-mers, with 0 being used
outside this range. The other parameters found to be
signiﬁcant for model input are shown in Figures 2 and 3.
The model with group 2 parameters’ output demon-
strated that some nucleotides and some internal
local stability values, as well as GþC composition, are
factors that inﬂuence siRNA eﬃcacy prediction. At
certain positions of the siRNA duplex, local stability
and identity of nucleotides are more important than in
others (Table 3). Model 2 was cross-validated using the
remaining experimental datasets (correlation coeﬃcients
and ROC curve areas were calculated for training and
testing datasets). A summary of the comparative results
for two models is shown in Figure 4. Group 2 parameters
improve the predictability of siRNA eﬃcacy. According to
the method’s correlation and sensitivity at highly speciﬁc
thresholds, the linear regression model, based on the
current study’s parameters from groups 1 and 2, predicts
siRNA eﬃcacy with comparable performance to the
earlier neural network models (8,10).
siRNA–scale web program. An interactive tool siRNA-
scale was created using JavaScript. The tool takes an
mRNA sequence as an input and splits the sequence into
21-mers. Antisense strands of these 21-mers include 30
overhangs (two nucleotides that are complementary to
target mRNA). For each potential siRNA candidate, the
tool outputs the sense 19-mer (overhanging two nucleo-
tides are not shown) and antisense 21-mer (overhanging
two nucleotides are shown) of the corresponding siRNA
and the predicted value of the siRNA eﬃcacy (remaining
amount of non cleaved mRNA in percentage towards
control). In the siRNA-scale output, the sequences of
siRNA candidates that are expected to lead to eﬃcient
Table 3. Nucleotides preferences and avoidance in the diﬀerent positions of antisense strand staring from 50 end
Nucleotides
AS/SS
Positions
Antisense strand (AS) 1234567891 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9
Sense Strand (SS) 19 18 17 16 15 14 13 12 11 10 987654321
A/U þþþþ þ þ    
G/C           þ
C/G         þ
U/A þþþ þþ þþ  
Plus and minus signs indicate that the presence or absence of relevant nucleotides at corresponding positions is related to siRNA eﬃcacy in a
signiﬁcant way at least in two experimental datasets. Plus sign means that the nucleotide is preferred in eﬃcient siRNAs; minus sign indicates
nucleotide avoidance.
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Figure 4. Statistical characteristics obtained for model 1 and 2. The
ﬁgure was created on the basis of the analysis of four databases. For
each database and approach, the area under a corresponding ROC
curve, as well as the correlation coeﬃcient between experimental and
theoretically predicted siRNA eﬃcacy, were calculated. The star near
the columns indicates that the relevant databases were used for
approach creation. The left part of the histogram shows correlation
coeﬃcients between experimentally obtained and predicted values of
siRNA eﬃcacy. The right part of the histogram shows values for the
areas under the ROC curves. The signiﬁcance values for correlation
coeﬃcients and ROC curve areas are shown in Supplementary Table 5
online.
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siRNA candidates are not highlighted. siRNA-scale can
also use as input a list of siRNA duplex antisense strands
from an experimentally obtained database, in which
eﬃcacy of each siRNA molecule is determined. This
option allows veriﬁcation of a method’s discriminatory
activity with newly produced experimental databases.
SiRNA-scales is located at http://gesteland.genetics.utah.edu/
siRNA scales.
DISCUSSION
The previous comparative analyses of siRNA design
approaches were performed when a smaller number of
approaches had been developed (1,15). With the interven-
ing expansion of databases and approaches, the compar-
ison performed here proved to be informative, with three
of the ten pre-existing approaches (8,10,11) faring better
than the others. The goals for performing this analysis
were (1) to compare the previously developed methods
and (2) to create a new, fast, transparent and user friendly
method for web-based siRNA design which is convenient
for diﬀerent groups of researchers.
Comparison of newlycreated siRNA design methodwith
previously reported methods
In this study we found that the newly created method is
comparable in its prediction eﬃciency to the three most
eﬃcient earlier methods. However the new method has
certain advantages. First, it is faster than the
ThermoComposition method by Shabalina-Ogurtsov
because it does not employ time-consuming RNA
secondary structure calculations (10,31). Second, linear
regression models generate lists of relative weighting of the
signiﬁcant model parameters, so, for similar parameters
such as nucleotide identity at certain positions, their
relative importance for predicting siRNA eﬃcacy can be
established. This is much more diﬃcult to achieve using a
neural network approach (8), which does not reveal the
relevant importance of its input parameters.
Third, the new method is transparent and this
permits insight to the underlying physical features of
siRNA-directed target cleavage. The improved transpar-
ency of the new method compared with neural networks,
for example, should facilitate further experimentation,
which is ultimately expected to lead to the design of better
algorithms and software.
Our work conﬁrms recent ﬁndings reported after we
completed our main analyses (11). We show that correla-
tions between siRNA eﬃcacy and local duplex stability
calculated as G0
37 values are strongest and most
signiﬁcant for the ﬁrst and last two duplex base pairs.
The recently published study demonstrates the heaviest
weighting for both these relevant G0
37 variables in the
linear regression model (11). We show here that some
instability for the two base pairs at the 6th and 13th
positions from the 50 end of the antisense strand correlates
signiﬁcantly with siRNA eﬃcacy while the other study
also shows elevated weighting for the relevant variables. In
addition, while creating model 2 we found that the
nucleotide composition of overhangs of siRNA duplex is
related to siRNA-directed cleavage eﬃciency. This ﬁnding
challenges the standard siRNA design approach of
introducing the dinucleotide ‘AA’ into the overhang
sequence. The recently published study (11) reached the
same conclusion.
Analysis of four diﬀerent databases allows us to reveal
universal features for eﬃcient siRNA prediction; however,
some ﬁndings were not mentioned in previous studies. For
example, we ﬁnd that local instability for the two base
pairs at the 7th, 10th and 12th positions correlates
signiﬁcantly with siRNA eﬃcacy. The preference of A at
positions 4, 7, 10, 14, 16, U at positions 2, 3, 7, 8, 13, 14,
avoidance of G at positions 2, 5, 13, 14, 17 and C at
positions 2, 3, 12, 13, 14 from the 50 end of the antisense
strand is not wholly consistent with the previous ﬁndings
(2,6,9,11). Because the correlations between siRNA
eﬃciency and nucleotide presence or absence are signiﬁ-
cant for at least two independent experimental databases,
we consider that our ﬁndings are reliable and will be
helpful for future regression model improvements.
The advantage of our model 2 compared to the
‘composite model’ of Vert et al. (11), is its much lower
number of input parameters. The ‘composite model’ uses
preferences for particular nucleotides at certain siRNA
antisense strand positions and total numbers of di- and tri-
nucleotide motifs in this strand as input parameters. The
total number of signiﬁcant input parameters for this
model is 115. Our model 2 uses thermodynamic values
related to local siRNA duplex stability, preferences for
particular nucleotides at certain antisense strand positions
and total GC content as input parameters. Its total
number of input parameters is 22. The signiﬁcant decrease
in the number of input parameters, also called dimension
reduction, is fundamental to multivariate statistical model
building. As the performance of our method is identical to
that of Vert and collegues (11), it is likely that these
additional parameters are redundant. These parameters
do not contribute to siRNA eﬃcacy prediction, but
instead obfuscate the truly important parameters for
siRNA eﬃcacy. Thus, our model generally provides a
better understanding of the underlying mechanism of the
process related to experimental data generation.
Relationship of group1and 2input parameters withthe
mechanismof siRNA-directed target cleavage
The process of siRNA-directed target cleavage involves
several reactions starting with RISC interacting with one
of the siRNA strands. Cleavage of the strand comple-
mentary to that selected by RISC and release of the
fragments generated ensues. RISC loaded with the
uncleaved guide strand interacts with the target, which is
then cleaved and released. The overall eﬃciency of the
process depends on the sum of the rates of each reaction.
The parameters of our models are related to these rates.
The algorithm’s group 1 parameters are related to the
chemical reaction that takes place before enzymatic
cleavage of target mRNA. One of the individual
parameters that correlates most strongly with siRNA
eﬃcacy is G0
37 calculated for the two 50 terminal
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to the rate of siRNA antisense strand entry into RISC.
Another parameter, G0
37, likely relates to the ratio of
rates of the antisense and sense strands for RISC entry
(see ‘Binding model for siRNA-RISC entry’ in
Supplementary Data, Materials section). Sense strand
entry into RISC is undesirable; it can cause competition
for RISC with the antisense strand and unspeciﬁc cleavage
of mRNAs partially complementary to the sense strand.
The majority of the algorithm’s group 2 parameters are
also likely related to reaction rates. Target interaction with
RISC loaded with the guide strand and subsequent
enzymatic target cleavage would be too slow if the
duplexes formed between siRNA antisense strands and
mRNA are insuﬃciently stable. However, target mRNA
and siRNA antisense strand secondary structures should
not be too stable. Otherwise target or siRNA antisense
strand unwinding will delay their subsequent interaction.
An optimal GC content should provide some trade-oﬀ
between optimal duplex stability and secondary structures
of target or siRNA antisense strand.
The potential signiﬁcance of the preference for parti-
cular nucleotides at certain positions of the siRNA
antisense strand is most likely related to the rates of
RISC binding or Argonaute 2 cleavage of the comple-
mentary strand.
Input parameters for our model are represented by the
combination of thermodynamic evaluations of local
duplex stability, preference for particular nucleotides at
certain strand positions and total GC content. During the
process of model ﬁtting some parameters are selected and
others are discarded as insigniﬁcant. At certain positions,
the nucleotide-related parameters are selected whereas at
others, local duplex stability related parameters are
selected. It is likely that the identity of the nucleotide is
more important than local duplex for the eﬃciency of
siRNA cleavage at some strand positions but at others,
the converse pertains. For example, the model ﬁtting
process prefers local stability values G7 and G13 in the
antisense strand over relevant nucleotide identities. So it is
likely that for eﬃcient siRNA-directed cleavage low
duplex stability at these positions is more important
than the presence of particular nucleotides. The rates of
melting of siRNA complementary target fragments
generated in the cleavage process are most likely related
to these local duplex stabilities.
Model transparency canimprove siRNA design
Model 1 was created using group 1 parameters on their
own and is almost as good as the other complete
approaches. It is the most important component of our
method. The underlying basis for its eﬃciency is under-
stood, and there is a known way to design any siRNA
duplex with superior antisense strand entry into RISC.
This can be achieved by introducing a mismatched
nucleotide near the 30 position of the siRNA sense
strand and chemical modiﬁcation of the 50 position of
the sense strand that blocks RISC entry (32,33). This
experimental approach can be used to create the next
generation of databases in which factors unrelated to
model 1 (group 2 parameters) can be unmasked and easier
to study. Dissection of group 1 and 2 parameters will
allow further optimization and use of only group 2
parameters for prediction of siRNA eﬃcacy.
Combination of our group 1 and 2 parameters with a
recently published scheme for optimal detection of
oligonucleotide hybridization targets common to families
of aligned sequences (34), permits prediction of optimal
targets for families of aligned viral RNA or DNA
sequences.
Finally, model transparency combined with compara-
tive analyses can, as shown here, reveal redundant
parameters in existing design algorithms. Redundant
parameters make models more complex without contri-
buting to model predictions and may obscure the
biological mechanisms for siRNA eﬃcacy.
Implications forthis work on thedesign of shRNA
The ﬁeld of RNA interference (RNAi) has continued to
advance rapidly; vector-based short hairpin RNA
(shRNA) technologies have evolved into an alternative
method of inducing RNAi. The transparency of our
method will facilitate the transfer of siRNA design rules to
shRNA. At least three considerations have to be taken
into account during this transfer. (1) Since shRNA-
derived siRNAs are likely present at a lower cellular
concentration than exogenously introduced siRNAs, the
optimal duplex stability and relevant GC content for
shRNA derivatives, can be diﬀerent. (2) Dicer processing
generates a few species of shRNAs from one predecessor
molecule of dsRNA or pre-microRNA (35), so the rules
of siRNA design may be applied to all possible species.
(3) Dangling end thermodynamic parameters for shRNAs
are most likely diﬀerent from those for siRNAs since in
the former they are represented by RNA and in the latter,
by DNA nucleotides. So the accumulation and study of
experimental shRNA databases currently being generated
by the scientiﬁc community should allow careful con-
sideration of these issues and relevant parameter
optimization.
In summary, a number of previously developed
approaches for eﬃcient siRNA design were compared,
and a new, transparent and eﬃcient method with low
number of input parameters was created together with an
accompanying web tool, ‘siRNA scale’, for its use.
METHODS
Parameters forthe models
To create models, we used two groups of parameters.
Group 1 parameters are related to terminal siRNA
duplex stability. Group 1 parameters include (1) G0
37
values which provide an estimate of the terminal stability
of the two nucleotides at siRNA duplex ends, (2) identity
of both nucleotides in 30 overhangs of an siRNA antisense
strand (20th and 21st positions) and (3) identity of the 1st
and 19th nucleotides of the antisense strand. Group 2
parameters include (1) GþC percentage of the antisense
strand, (2) identity of nucleotides from the 2nd to 18th
positions in the siRNA antisense strand and (3) local
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the siRNA antisense strand.
Parameter calculations
The G0
37 calculations related to duplex terminal and
the local stability parameters used were thermodynamic
parameters published earlier (26–30,36). The G0
37 value
was calculated for the two terminal nucleotide base pairs
of each siRNA duplex by subtracting the G0
37 value for
the 50 sense strand from that of the 50 antisense strand.
Statistical analyses
For ROC and regression analyses, we used a set of
commercially developed Excel macros that are available
from http://www.analyse-it.com. For correlation analyses,
the normalized levels of mRNA or protein products
remaining in cells after siRNA treatments were expressed
as percentage values of the control levels. For categoriza-
tion analysis, siRNAs that yielded at least 70% target gene
knockdown were considered to be eﬃcient. We compared
the approaches by analyzing their receiver operating
characteristics (ROC) curves. An ROC curve describes
the relationship between the speciﬁcity Sp¼TN/
(FPþTN) and the sensitivity Se¼TP/(TPþFN) of an
algorithm. Here, TP, FP, TN and FN are the number of
true positives, false positives, true negatives and false
negatives. A prediction is true positive if the siRNA is
both predicted and experimentally known to be eﬃcient;
true negative if it is both predicted and experimentally
known to be ineﬃcient; false positive if it is predicted to be
eﬃcient but experimentally found to be ineﬃcient; and
false negative if predicted to be ineﬃcient but found to be
eﬃcient. In the area tests, we calculate the area under the
ROC curve, also known as the ROCscore. An area of 1
indicates a perfect classiﬁcation, and an area of 0.5
indicates a random classiﬁcation. The ROCIT software
(37) was applied for the calculation of signiﬁcance levels
for ROC area comparisons.
SUPPLEMENTARY DATA
Supplementary Data is available at NAR Online.
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APPENDIX
Note 1
The term ‘parameter’ in our work can be replaced by term
‘argument’, since it is more correct from a formal
mathematics perspective. We avoided this replacement,
since in biological articles on similar topics the term
‘parameter’ is used in the sense of a mathematical
argument.
Note 2
The non-scoring algorithm described by Ui Tei-Saigo
(‘‘version 1’’) was modiﬁed to become a scoring algorithm,
which would be more comparable with the other scoring
algorithms studied here. This modiﬁed algorithm, here
called version 2, performs better than the original
algorithm. Ui Tei-Saigo’s non-scoring algorithm predicted
eﬀective if the siRNA satisﬁed the algorithm’s four
eﬃcacy parameters.. (1) A/U at the 50 end of the antisense
strand; (2) G/C at the 50 end of the sense strand; (3) at least
ﬁve A/U residues in the 50 terminal one-third of the
antisense strand; and (4) the absence of any GC stretch of
more than 9nt in length.
The following scores were assigned to this algorithm’s
parameters: (1) A/U at the 50 end of the antisense strand
was assigned the value of þ1 point; (2) G/C at the 50 end
of the sense strand was assigned the value of þ1 point,
(3) at least ﬁve A/U residues in the 50 terminal one-third of
the antisense strand was assigned the value of þ1 point;
and (4) The presence of any GC stretch of more than 9nt
in length in the siRNA duplex was assigned the value of
 3 points.
In addition, we also assigned minus to all positive
correlation coeﬃcients derived from the algorithms. The
absolute values of the correlation coeﬃcients remained the
same. This procedure was done for easier graphical
comparison of correlation coeﬃcients as the great
majority is negative. This modiﬁcation did not inﬂuence
the algorithms’ discriminative capacity.
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